TypeCauseTime courseThyroid functionRAIU at 24 hoursAnti-TPO antibodiesPrevalence or incidence
Painful
Subacute granulomatousInfection (viral)SubacuteHyper, hypo, or both, then normal< 5 percentLow or absent titerFour to five cases per 100,000 persons
SuppurativeInfection (nonviral)Acute (nonbacterial may be subacute)NormalNormalAbsentUndetermined but very rare
Radiation or traumaDestruction of thyroid parenchymaAcuteHyper, hypo, or normal< 5 percentAbsent*1 percent of those receiving131I for Graves' disease
Painless
Hashimoto's diseaseAutoimmuneChronicNormal or hypoNormal or lowHigh titer, persistent5 to 10 percent
PostpartumAutoimmuneSubacuteHyper, hypo, or both, then normal< 5 percentHigh titer, persistent5 to 7 percent of postpartum women
Subacute lymphocyticAutoimmuneSubacuteHyper, hypo, or both, then normal< 5 percentPresent, persistent10 to 15 cases per 100,000 persons
Drug-induced
Amiodarone (Cordarone)InflammationAcute or subacuteHyper or hypoLowAbsent10 percent
Interferon-alfa (Infergen; Intron A, Roferon-A, Rebetron combination therapy)InflammationAcute or subacuteHyper or hypoLow5 to 10 percent positive10 to 15 percent
Interleukin-2InflammationAcute or subacuteHyper or hypoLow< 10 percent positiveUndetermined
LithiumAutoimmuneAcute or subacute Hyper then normal, or low Low33 percent positive13 cases per 100,000 persons
Riedel'sFibrosisChronicNormal or lowNormal or lowPresentUndetermined